Can a coin flip decide chemo for AML patients? new study aims to find out.

NCT ID NCT07094750

First seen Jan 04, 2026 · Last updated May 01, 2026 · Updated 18 times

Summary

This study looks at whether less fit adults with acute myeloid leukemia (AML) are willing to let a computer randomly assign them to either lower- or higher-intensity chemotherapy. The goal is to see if patients are open to this approach, which could help doctors learn the best treatment intensity for this group. About 50 participants will be surveyed about their willingness to randomize. The study does not provide treatment itself but gathers information to guide future research.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.